Engineered stem cell exosomes for oral and maxillofacial wound healing
Open Access
- 24 October 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 10, 1038261
Abstract
Wound healing of the oral and maxillofacial area affects the quality of life and mental health of the patient; therefore, effective therapies are required to promote wound healing. However, traditional treatment methods have limited efficacy. Exosomes secreted by stem cells used for oral and maxillofacial wound healing have shown outstanding results. Stem cell-derived exosomes possess the regenerative and repair ability of stem cells. Moreover, they are nontumorigenic and have good biosafety. However, the application of natural stem cell exosomes is limited owing to their low yield, impurity, lack of targeting, and low drug delivery rate. Many modification methods have been developed to engineered stem cell exosomes with beneficial properties, such as modifying parent cells and directly processing stem cell exosomes. These methods include coincubation, genetic engineering, electroporation, ultrasound, and artificial synthesis of engineered stem cell exosomes. These engineered stem cell exosomes can cargo nucleic acids, proteins, and small molecules. This gives them anti-inflammatory and cell proliferation regulatory abilities and enables the targeted promotion of efficient soft tissue repair after trauma. Engineered stem cell exosomes can decrease inflammation, promote fibroblast proliferation, and angiogenesis, and decrease scar formation to promote oral and maxillofacial wound healing, including diabetic and burn wounds. Thus, engineered stem cell exosomes are an effective treatment that has the potential for oral and maxillofacial wound healing.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (Nos. 2019JCKT-70 2020JCXK-45)
- Department of Science and Technology of Jilin Province (No. JJKH20221093KJ)
- Department of Finance of Jilin Province (No. JCSZ2019378-8 jcsz2021893-13)
- Jilin Provincial Scientific and Technological Development Program (20210101010JC 20220505033ZP 20200801077GH)
- Changchun Science and Technology Bureau (No. 21ZY26)
This publication has 162 references indexed in Scilit:
- FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly DeliverPharmaceuticals, 2013
- Egr‐1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)The Journal of Pathology, 2012
- Exosome mimetics: a novel class of drug delivery systemsInternational Journal of Nanomedicine, 2012
- Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophagesJournal of Translational Medicine, 2011
- A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in ExosomesMolecular Therapy, 2010
- Liposome‐bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritisArthritis & Rheumatism, 2010
- Structural-Mechanical Characterization of Nanoparticle Exosomes in Human Saliva, Using Correlative AFM, FESEM, and Force SpectroscopyACS Nano, 2010
- Large-Scale Proteomics and Phosphoproteomics of Urinary ExosomesJournal of the American Society of Nephrology, 2009
- Wound repair and regenerationNature, 2008
- Thermosensitive Hydrogel PEG–PLGA–PEG Enhances Engraftment of Muscle-derived Stem Cells and Promotes Healing in Diabetic WoundMolecular Therapy, 2007